These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30690466)

  • 1. Further observation of travellers taking twice-weekly atovaquone-proguanil prophylaxis in sub-Saharan Africa.
    Biber A; Harel R; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30690466
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
    Meltzer E; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of atovaquone-proguanil during pregnancy.
    Mayer RC; Tan KR; Gutman JR
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E
    J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 8. Atovaquone/proguanil: the need for family protection.
    Kain KC
    J Travel Med; 2003 May; 10 Suppl 1():S8-12; discussion S21. PubMed ID: 12737754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsing malaria: two cases of malaria presenting 8 months after return from Africa despite adherence to antimalarial chemoprophylaxis.
    Morgan GS; Chiodini P; Evans M
    Br J Gen Pract; 2012 Oct; 62(603):555-6. PubMed ID: 23265223
    [No Abstract]   [Full Text] [Related]  

  • 10. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD;
    Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
    Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O
    Malar J; 2013 Nov; 12():399. PubMed ID: 24200190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluindione and falciparum malaria treated by atovaquone-proguanil].
    Kamaliddin C; Joste V; Argy N; Houzé S
    Therapie; 2018 Oct; 73(5):445-447. PubMed ID: 29680373
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimalarial pharmacology and therapeutics of atovaquone.
    Nixon GL; Moss DM; Shone AE; Lalloo DG; Fisher N; O'Neill PM; Ward SA; Biagini GA
    J Antimicrob Chemother; 2013 May; 68(5):977-85. PubMed ID: 23292347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.
    Schnyder JL; de Jong HK; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2022; 49():102365. PubMed ID: 35661741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of atovaquone-proguanil?
    Croft A; Geary K; Morgan L
    Lancet; 2001 Apr; 357(9264):1289-90. PubMed ID: 11421209
    [No Abstract]   [Full Text] [Related]  

  • 19. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
    Boggild AK; Parise ME; Lewis LS; Kain KC
    Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study.
    Schlagenhauf P; Tschopp A; Johnson R; Nothdurft HD; Beck B; Schwartz E; Herold M; Krebs B; Veit O; Allwinn R; Steffen R
    BMJ; 2003 Nov; 327(7423):1078. PubMed ID: 14604928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.